Charlotte Pooley Deckhut

This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Janssen Pharmaceutica Nv. Active years: 2015-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charlotte Pooley Deckhut. Retrieved from https://idiyas.com/inventor/charlotte-pooley-deckhut

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 2)

% Patents Active = 66.7

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 14.2

ph-index = 3

Forward Citations = 14(Granted Patents)

Company Filing History:

12 out of 2,101

Janssen Pharmaceutica Nv

patents

Years Active: 2015-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065446 - Inhibitors of Bruton's tyrosine kinase and method of their use (2024-08-20),

2. 12024524 - Imidazopyridazines as modulators of IL-17 (2024-07-02),

3. 11319329 - Inhibitors of Bruton's tyrosine kinase and methods of their use (2022-05-03),

4. 10934310 - Inhibitors of Bruton's tyrosine kinase and method of their use (2021-03-02),

5. 10822348 - Inhibitors of Bruton's tyrosine kinase and methods of their use (2020-11-03),

6. 10800792 - Inhibitors of Bruton's tyrosine kinase and method of their use (2020-10-13),

7. 10717745 - Inhibitors of Bruton's tyrosine kinase and method of their use (2020-07-21),

8. 10689396 - Inhibitors of Bruton's tyrosine kinase and methods of their use (2020-06-23),

9. 9682972 - 1,2,5-substituted benzimidazoles as flap modulators (2017-06-20),

10. 9682971 - 1,2,5-Substituted benzimidazoles as flap modulators (2017-06-20),

11. 9265770 - 1,2,5-substituted benzimidazoles as FLAP modulators (2016-02-23),

12. 9067917 - 1,2,5-substituted benzimidazoles as FLAP modulators (2015-06-30),

Title: The Innovative Contributions of Charlotte Pooley Deckhut

Introduction

Charlotte Pooley Deckhut is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. Her work focuses on developing innovative compounds that have the potential to address various medical conditions.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Inhibitors of Bruton's tyrosine kinase and method of their use." This patent discloses compounds of Formula (I) and outlines methods for their use and preparation, as well as compositions that include these compounds. Another notable patent is "Imidazopyridazines as modulators of IL-17," which presents compounds that can be used for treating or ameliorating IL-17 mediated syndromes, disorders, and diseases.

Career Highlights

Charlotte is currently employed at Janssen Pharmaceutica NV, where she continues to push the boundaries of pharmaceutical research. Her dedication to innovation has positioned her as a key player in her field, contributing to advancements that can improve patient outcomes.

Collaborations

Throughout her career, Charlotte has collaborated with esteemed colleagues, including James Patrick Edwards and Nidhi Arora. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Charlotte Pooley Deckhut's contributions to the field of pharmaceuticals through her innovative patents and collaborative efforts exemplify her commitment to advancing medical science. Her work continues to inspire future innovations in the industry.

Profile summary based on public USPTO records.